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Abstract: Well-differentiated papillary mesotheliomas (WDPMs)
are usually encountered as incidental findings in the peritoneal
cavity in women. Most WDPMs are benign, and the histologic
features that indicate a more aggressive course are controversial.
We report 20 cases of WDPM, which contained invasive foci.
Thirteen cases arose in the peritoneal cavity, 1 in a hernia sac, 3
in the pleural cavity, and 3 in hydroceles. The female:male ratio
was 16:4, and age range was 7 to 74 years. Tumor was multifocal
in 15 cases. Some tumors showed back-to-back papillae, a pat-
tern mimicking invasion but discernible on pan-keratin stain as
compressive crowding. True invasive patterns ranged from
simple bland-appearing glands invading the stalks of the papil-
lae to solid foci of invasive tumor of higher cytologic grade than
the original WDPM. All 5 tested cases were negative for p16
deletion by fluorescence in situ hybridization, but 2/3 had
abnormal karyotypes. Recurrences were seen in 8 patients, and
in 4 multiple recurrences were documented. Of 16 patients with
follow-up, 14 are alive from periods of 6 months to 6 years
(average 3.5 y), and 2 have known recurrent disease. One patient
died of disseminated tumor at 8 years but without histologic
confirmation of the nature of the tumor. We conclude that
WDPM with invasive foci in the papillae appear to be prone to
multifocality and recurrence, but that they rarely give rise to life-
threatening disease. We suggest that these lesions be called
WDPM with invasive foci to alert clinicians to the possibility of
recurrence.
Key Words: well-differentiated papillary mesothelioma, malig-
nant mesothelioma, p16 deletion
(Am J Surg Pathol 2014;38:990–998)
Well-differentiated papillary mesotheliomas (WDPMs)are characterized by a mesothelial proliferation
with a papillary architecture, a myxoid appearance to the
papillary cores, and a single layer of cytologically bland
mesothelial cells covering the papillae.1 Most WDPMs
are found in the peritoneum in women, but they also
occur in the pleural cavity, pericardium, and tunica
vaginals.
The neoplastic versus non-neoplastic nature of
WDPM and the question of how these lesions behave has
always been somewhat controversial. WDPMs are
sometimes multifocal and occasionally recur after surgical
excision, but, at least in the peritoneal cavity, neither
multifocality nor recurrence has clearly been associated
with an adverse prognosis.2,3 A related question is
whether WDPMs ever give rise to diffuse malignant
mesothelioma or whether these are completely separate
lesions. This issue has been raised in various papers,
but very few verifiable cases of WDPM developing
into malignant mesothelioma have been reported (see the
Discussion section).
In this paper, we report a series of 20 WDPMs
containing invasive foci, look at the effect of such foci on
recurrence and survival, and ask whether there is any
clear relationship between WDPM and malignant meso-
thelioma.
METHODS
Cases of possible WDPM with invasion were se-
lected from the authors’ consult files. Thirty-one cases
were submitted for review by all the authors, and after
initial review 20 were accepted as true WDPM with
invasive foci. All tumors had a largely papillary archi-
tecture, with the papillae being formed of myxoid-
appearing cores and a covering composed of a single layer
of relatively bland-appearing mesothelial cells. Invasive
foci or higher-grade tumor within the overall papillary
structures was considered a part of the entity of WDPM
with invasive foci, but areas of solid tumor outside the
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papillary structures were viewed as diffuse malignant
mesotheliomas and were not accepted as WDPM. In 1
case (case 13) there was a small invasive focus in the fat
under the WDPM. Immunohistochemical staining results
showing a mesothelial origin were available for all except
2 of the cases. Clinical features including location, mul-
tifocality, recurrence, survival, and follow-up looking for
evidence of diffuse malignant mesothelioma were re-
corded. This study was approved by the University of
British Columbia Committee on Human Research Ethics.
p16 Fluorescence In Situ Hybridization Testing
In 5 cases, p16 fluorescence in situ hybridization
(FISH) testing was performed to look for p16 deletion.
Briefly, 4-mm-thick formalin-fixed paraffin-embedded
sections were deparaffinized and pretreated using a
VP2000 processor (Abbott Laboratories). After depar-
affinization and rehydration, the slides were acid treated
in 0.2N HCl for 20 minutes, washed in 2X SSC, placed in
8.1% sodium thiocyanate, washed in 2X SSC, digested in
0.8% pepsin for 10 minutes, washed in 2X SSC, and
postfixed in 10% neutral buffered formalin. Slides were
then denatured for 16 minutes at 791C and then hybri-
dized with a CDKN2A/CC9 probe (Cymogen Diag-
nostics) that was diluted 1:10 in Denhyb probe
hybridization buffer (Insitus) and then incubated over-
night (14 to 16 h) at 371C. The Cymogen CDKN2A/CC9
probe comprises a 298 kb orange fluor–labeled probe to
9p21.3 and a green fluor–labeled probe to the centromeric
region of chromosome 9 (9p11.1-q11.1). After incubation,
slides were washed for 3 minutes in 0.4X SSC/0.3% NP40
at 791C, followed by washing at 251C in 2X SSC for
3 minutes, and quick rinse in dH2O. After air drying,
slides were counterstained using DAPI/Fluorguard sol-
ution and then coverslipped. Slides were then scanned
using a Metasystems slide scanner (MetaSystems,
Altlussheim, Germany). A positive homozygous deletion
event is defined as a DAPI-stained nucleus with no
orange signals and at least 1 green signal. Using the
Metasystems captured images, at least 50 to 100 nuclei
were counted for each case, and the percentage of positive
nuclei was calculated. The threshold, to account for
section truncation artifact, for p16 homozygous deletion
for this assay on formalin-fixed paraffin-embedded sec-
tions is 12%.
Karyotype Analysis
Chromosome analysis was performed using stand-
ard methods. Briefly, fresh tumor specimens collected
after surgery were washed with an antimycotic (0.5 mg/mL
Amphotericin B) and antibiotics (200 IU/mL penicillin
and 200 mg/mL streptomycin), minced, and digested
overnight with collagenase (200U/mL) in complete
DMEMmedium. Dissociated cells were washed twice and
then cultured in complete DMEM medium supplemented
with epidermal growth factor and insulin-transferrin-so-
dium selenate (Life Technologies). The cultures were
monitored daily, and appropriately confluent cells were
subjected to metaphase preparations using standard
methods after addition of colcemid for 12 hours. Meta-
phase preparations were subjected to GTG banding and
analyzed by standard methods. The karyotypes were de-
scribed by standard cytogenetic nomenclature.
RESULTS
Demographic and Clinical Features
Twenty cases were accepted on review as showing
an underlying pattern of WDPM with invasive foci.
Table 1 shows demographic data and lists the sites and
sizes of the lesions. There were 16 women and 4 men with
an age range from 7 to 74. The majority of cases (13)
arose in the peritoneal cavity, whereas 1 developed in a
hernia sac, 3 in the pleural cavity, and 3 in hydrocele sacs.
Pathologic Findings
In 15 cases the lesions were multifocal. Tumor sizes
ranged from <1 to 12 cm. Although all tumors showed a
typical microscopic pattern of WDPM (Figs. 1A, 2A,
C, 3A, 4A), in 6 cases the lesions had undergone a phe-
nomenon that we view as compressive crowding; that is,
the usual spaced papillae characteristic of WDPM
(Fig. 1A) were replaced by back-to-back papillae
(Figs. 1A, B), an appearance that at first glance mimicked
an invasive tumor. However, keratin stains (Fig. 1C)
showed clearly that outlines of the original papillae were
still visible. Lesser degrees of compressive crowding than
shown in Figures 1A–C were seen in some of the other
cases. In all cases the papillae were covered by a single
layer of flattened to cuboidal cells, and in some cases
these cells had prominent nucleoli; however, multilayering
of the covering cells and marked cytologic atypia were
never present.
Immunohistochemical staining information was
available for 18/20 cases and showed a typical pattern of
mesothelial markers (Table 2). One case (case 19) was an
incidental microscopic finding and was cut through on
initial hematoxylin and eosin, therefore immunostaining
could not be performed, and for 1 case (case 6) im-
munostaining results were not available.
Invasive foci always constituted a small area of the
lesion. A wide variety of invasive patterns was seen
(Figs. 1D–F, 5A, B, 2B, D, 3B). These included small
bland-appearing mesothelial glands in a fibrotic stroma,
solid or near solid areas of bland mesothelial cells
(Figs. 1F, 5A, B, 2D), solid sheets of spindled cells
(Fig. 2B), and, much less frequently, cytologically higher-
grade lesions appearing as sheets of atypical mesothelial
cells or atypical cells forming glands (Figs. 1D, E, 3B).
For the most part the invasive foci tended to be super-
ficial and were confined to the polyp that constituted the
WDPM lesion, but in 1 case (case 13) they invaded fat
(Fig. 4). In 1 case (case 10) several separate invasive foci
were present.
p16 FISH testing was performed on the invasive foci in
5 cases (Table 2), and none showed p16 deletion. Kar-
yotyping was successfully performed on 3 cases (Table 2);
because the invasive foci were only microscopic findings, the
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karyotypes were derived from the whole WDPM lesions. Of
these, 2 cases revealed clonal abnormalities, whereas the
third case yielded a normal karyotype. Of the 2 cases
with nonrandom chromosome aberration, 1 showed
46,XX,del(14)(q12q24),t(15;16)(q22;p13.3),add(21)(q22) in 7
of 16 metaphases analyzed. The other tumor showed
46,XX,-4,+del(6)(q13),del(10(p11.2),-22,+mar[cp8].
Follow-up
A number of patients were treated by cytoreductive
surgery and chemotherapy, whereas in the remainder re-
current lesions were simply removed. Follow-up data
were available for 16 patients. Recurrence of WDPM was
seen in 8 patients, and in 4 of these patients there were
multiple recurrences (Table 1). Fourteen patients are alive
at the last follow-up (range 6mo to 6 y, mean 3.5 y). Two
patients are alive with apparently recurrent but non-
progressive disease. One patient died of acute myeloge-
nous leukemia. In 1 patient (case 17) there was clinical
evidence of disseminated disease leading to death after 8
years. However, no histologic confirmation of the nature
of the disseminated disease was available (see the Dis-
cussion section).
DISCUSSION
WDPM continues to be an enigmatic lesion, with
opinions about its nature running the gamut from a non-
neoplastic reactive process to a benign tumor, a low-grade
neoplasm or neoplasm of uncertain malignant potential,
or a form of malignant mesothelioma; indeed sometimes
these cases are treated clinically as if they were malignant
mesotheliomas, as is evident in Table 1.
Both clinical behavior and (limited) molecular
analyses suggest that WDPMs are in fact neoplastic.
Ribeiro et al7 reported 2 cases in sisters that they believed
represented WDPM and that showed BAP1 mutations,
something that has been described in unequivocal diffuse
malignant mesotheliomas.6,8 On review their case 1 ap-
pears to us to actually be an ordinary malignant meso-
thelioma, but case 2 is most likely a WDPM with
invasion, although the possibility that this is really an
ordinary diffuse malignant mesothelioma with a papillary
area cannot be ruled out.
In the present study, none of the 5 cases analyzed
had p16 deletions, another common finding in diffuse
malignant mesotheliomas,9 but 2 of 3 tumors attempted
for karyotype exhibited clonal chromosome aberrations.
Chromosome abnormalities in malignant tumors arising
from the pleura are generally complex and involve almost
all chromosomes (http://cgap.nci.nih.gov/Chromosomes/
RecurrentAberrations). No specific chromosome trans-
locations have been reported in mesotheliomas. The most
frequent aberrations are monosomies, deletions, or gains
of chromosomes. The common chromosome losses are
22, 13, 14, and 4, gain of chromosome 7, and deletion
involving 1p, 3p, 6q, and 9p. One of our cases showed






Noninvasive Areas? Treatment/Recurrence Status




2 35 F Peritoneum Multiple Yes Original bx 2006. Recurrences 2007, 2008 A&W 2103
3 35 F Peritoneum Single 12 cm mass 2009 No Original bx 3/09. Recurrence 10/09 A&W 2013
4 41 F Peritoneum Multiple No Original bx 2007. Recurrences2 2008 A&W 9/2012
5 20 F Peritoneum Multiple No Recurrence in 2006 (original date of dx unknown) A&W 8/2010
6 7 F Peritoneum Single No Recurrence age 11 Lost to follow-up
7 35 F Hernia Multiple No No recurrence A&W 6y
8 67 M Hydrocele Single 2.5 cm Yes Hemiscrotectomy/no recurrence A&W 3y
9 45 M Hydrocele Multiple No Hydrocele resection A&W 1y
10 27 F Peritoneum Single 7 cm Yes Recurrence at 8 and 11mo A with disease 1 y
11 56 M Hydrocele Multiple Yes No information available Lost to follow-up
12 32 F Peritoneum Multiple, largest 8 cm No Cytoreductive surgery and chemotherapy A&W 2y
13 30 F Peritoneum Multiple, largest 6m No Cytoreductive surgery and chemotherapy Lost to follow-up
14 38 F Peritoneum Multiple, largest 0.5 cm No Treated for AML, no autopsy Died of AML
15 37 F Peritoneum Multiple, up to 2 cm No Cytoreductive surgery and chemotherapy A&W 25mo
16 74 M Pleural Multiple No Chemotherapy A with disease, 6mo
17 62 F Pleural Multiple No 2003 chemotherapy, radiation, extrapleural
pneumonectomy
Died of disease, 2011
(no histologic
confirmation)
18 65 F Pleural Multiple No Diagnosed 2004, treated with chemotherapy A&W 2012
19 58 F Peritoneal Single No Incidental finding on tubal serosa (prophylactic
salpingo-oophorectomy for BRCA1 carrier)
Recent case
20 53 F Peritoneal Multiple No WPDM resected 1999. Recurred 2001, treated
with peritoneal stripping and intraperitoneal
chemotherapy. New recurrence 2012 treated
with partial colectomy
A&W 2012
A indicates alive; AML, acute myelogenous leukemia; A&W, alive and well.
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FIGURE 1. Peritoneal WDPM with areas of compressive crowding and invasive foci (case 10). A, Typical area of WDPM with
myxoid-appearing papillae covered by a single layer of mesothelial cells in the center of the field and compressive crowding at the
right hand edge. B, Another area of compressive crowding at higher power; this appearance leads to a false impression of invasive
tumor. C, Pan-keratin stain outlines the retained papillary structure in the areas of crowding. D and E, Invasive focus with a
somewhat complicated architecture and higher cytologic grade. F, Another invasive focus with a solid nodule of bland epithelial
mesothelial cells. Taken by themselves these invasive foci are indistinguishable from diffuse malignant mesothelioma.
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losses of chromosomes 4, 22, and 6q deletion. The second
case showed deletion of a large part of 14q, which is
equivalent to loss of 14. Thus, both the chromosomally
abnormal karyotypes that we obtained from WDPM
showed similarities to chromosome changes seen in
pleural mesotheliomas. Translocations in 15q22 and
16p13.3 have been described in hematologic malignancies
and rare solid tumors, but the specific translocation
between 15 and 16 seen here has not been previously
described.10
The fact that WDPM can recur also favors a neo-
plastic process. Information on recurrence is difficult to
glean from the literature, but in the recent Malpica et al2
study recurrence was observed in only 1 of 22 patients.
Interestingly, Malpica and colleagues described areas that
we would call low-grade invasive foci in 15 of 26 patients.
In contrast, the present series has a higher rate of re-
currence (8 of 20 cases), and, in several cases, multiple
recurrences, which leads us to suggest that WDPM with
invasive foci may be particularly prone to recurrence.
Part of the problem in understanding the behavior
of WDPM lies in the morphologic definition. The series
of cases reported by Daya and McCaughey3 is usually
viewed as the first clear description of these lesions, but in
fact the Daya and McCaughey cases, although described
as being papillary in part in all cases, also had a broad
range of other patterns. The one papillary area illustrated
by Daya and McCaughey is not all that similar to the
FIGURE 2. A WDPM arising in the peritoneum (case 2). Original tumor in the peritoneum (A and B) and recurrent tumor 1 year
later (C and D). Low-power views show typical WDPM patterns (A and C), but in (B) there is an invasive focus of proliferating
spindle cells, and in (D) an invasive focus composed of compact simple tubules.
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lesion currently accepted by most authors as WDPM, and
diagnostic criteria for WDPM appear to have slowly
changed over time.
More recent descriptions of WDPM have all em-
phasized the rather specific papillary component with
more or less myxoid and typically fairly plump cores with
a single layer of overlying bland mesothelial cells as the
essential feature of WDPM,4,11–19 even though in some
instances different names have been applied to the lesion.
Goldblum and Hart14 simply referred to them as
“localized mesotheliomas,” and Brimo et al12 called them
“mesotheliomas of uncertain malignant potential.”
Whether WDPM can transform into lesions of
higher malignant potential, including diffuse malignant
mesotheliomas, is a controversial issue. One of the
confounding factors in this regard is that large WDPM
can undergo what we regard as compressive crowding
of the papillae (Fig. 1). Some reports have viewed such
areas as cribriform (potentially invasive) patterns and
possibly indicative of a worse prognosis (eg, Brimo et al12
and Trpkov et al16), and the term “mesothelioma of
uncertain malignant potential” has been applied to
such lesions,12 but what this really appears to be is
compression of the papillae together, leaving lines of what
FIGURE 3. Invasive focus arising in a WDPM in a hydrocele (case 8). Low power (A) shows a typical WDPM architecture but with a
solid invasive focus in the center; this focus is shown at higher power in (B). Note the higher cytologic grade.
FIGURE 4. Invasion of the fat in a peritoneal WDPM (case 13). A, Typical picture of WDPM. B, An area in which bland-appearing
mesothelial cells invade the fat underneath the tumor.
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were originally surface mesothelial cells producing a false
impression of “invading” stroma. Keratin stains show
that the original papillary structure with covering meso-
thelial cells is still intact and that this pattern is not in-
vasion (Fig. 1). It is possible that labeling such cases as
true malignant mesotheliomas may account in part for
the far better survivals seen in peritoneal compared with
pleural mesotheliomas, even, sometimes, with what would
appear to be inadequate therapy for a malignant meso-
thelioma.5
Nonetheless, there are morphologic changes in
WDPM that we believe have to be regarded as true in-
vasion, even though the original authors did not regard
them as such. For example, the original Daya and
McCaughey3 paper illustrates a pattern that is funda-
mentally identical to an epithelial mesothelioma with a
tubulopapillary pattern, and a similar picture is shown by
Malpica et al2 (their Fig. 1F).
Daya and McCaughey3 contended that these were
extremely bland cells and hence not malignant, but cy-
tologic grade is a poor indicator of malignancy in epi-
thelial mesotheliomas, many of which are remarkably
bland appearing. Malpica et al2 also showed an image of
glands from a WDPM invading the ovarian cortex (their
Fig. 3); it is hard to see how such patterns cannot be
viewed as malignant. The same is true of areas such as
our Figures. 1D–F, 5A, B, 2B–D, 3B, and 4B. We sug-
gest, however, that when such areas are low grade and
localized to the papillae of WDPM, even though they
morphologically mimic malignant mesotheliomas (albeit
in very small areas), they generally do not give rise to
diffuse malignant mesotheliomas. However, they may
predispose to multifocality and recurrence. Indeed, it is
striking that, in the cases in which we had material
available for review from recurrences, the recurrences of
these tumors had the morphology of WDPM and not
malignant mesotheliomas (eg, Figs. 2A, C).
Most reports in the literature on malignant meso-
thelioma developing in WDPM either lack convincing
illustrations (eg, Washimi et al,20 who are illustrating re-
active mesothelial hyperplasia and not WDPM) or have
such a long time interval between the diagnosis of
WDPM and mesothelioma (eg, 10 y in the 2 cases re-
ported by Galateau-Salle´ et al13) that it is difficult to
be sure that the WDPM and subsequent malignant
mesothelioma are connected. One of our cases had an
TABLE 2. Immunohistochemical and Molecular Data
Case Immunohistochemical Staining Results Molecular Testing Results
1 Positive: calretinin, weak BerEP4 Not done
Negative: B72.3, CEA, CD15
2 Positive: calretinin, WT-1, p16 p16 not deleted by FISH
Negative: CK5/6 46,XX,-4,+del(6)(q13),del(10)(p11.2),-22,+mar[cp8]
3 Positive: CK7, CK5/6, calretinin mesothelin, p16 46,XX,del(14)(q12q24),t(15;16) (q22;p13.3),add(21)(q22)[7]/46,xx[9]
Negative: BerEP4, CEA, CD15, p53
4 Positive: calretinin, WT-1, D2-40, p16, PR Not done
Negative: CEA, B72.3, BerEP4, CD15, CK5/6, TTF-1
5 Positive: calretinin, WT-1, D2-40, p16 Not done
Negative: CK5/6, CEA, B72.3, BerEP4
6 Information not available Not done
7 Negative: CEA, B72.3, CD15 Not done
8 Positive: calretinin, CK5/6 p16 not deleted by FISH
Negative: CEA
9 Positive: calretinin, WT-1, D2-40 Not done
Negative: CEA, BerEP4, MOC-31, CK5/6 CD15
10 Positive: calretinin, WT-1 p16 not deleted by FISH
11 Positive: calretinin, WT-1, CK5/6 Not done
Ki67<5%
12 Positive: calretinin, CK5/6, CK7 Not done
Negative: MOC-31
13 Positive: calretinin, WT-1 Not done
Negative: MOC-31, ER
14 Positive: calretinin, CK5/6 Not done
Negative: MOC-31
15 Positive: calretinin, CK5/6 Not done
Negative: MOC-31
16 Positive: calretinin, CK5/6 Not done
Negative: MOC-31, CEA
17 Positive: calretinin, CK5/6, p53, p16 p16 not deleted by FISH
Negative: BerEP4
18 Positive: calretinin, CK5/6, EMA (membrane) Not done
Negative: BerEP4, TTF-1, p53
19 Lesion cut through, no IHC done Not done
20 Positive: calretinin, WT-1 p16 not deleted by FISH
Negative: D2-40
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extrapleural pneumonectomy but died of disseminated
disease after 8 years (case 17). Unfortunately we have not
been able to retrieve the pathology samples from the
extrapleural pneumonectomy, so the nature of the
progressive tumor is not known.
There are a few examples in the literature in which
there does appear to be a connection between WDPM
and a subsequent malignant mesothelioma. Torii et al15
reported a multifocal WDPM in the pleura with clear
invasion of the lung and chest wall in the extrapleural
pneumonectomy specimen, but, interestingly, no re-
currence was reported up to 8 months. Bu¨rrig18 described
a man with multiple peritoneal WDPM on biopsy who
developed ascites 1 year later and died of a diffuse ma-
lignant mesothelioma of the peritoneum 5 years later, and
Butnor et al11 reported a man with a peritoneal WDPM
who developed radiologically progressive disease and died
3 years later but unfortunately without autopsy con-
firmation of the diagnosis.
We believe that several of the cases in this series do
show a potential connection between WDPM and malig-
nant mesothelioma, but for the most part these were
represented by focal areas of higher cytologic grade and/
or architectural complexity (Figs. 1D, E, 3B). In case 13,
there was invasion of underlying fat (Fig. 4B), which was
unequivocal evidence of malignancy. Unfortunately this
case was lost to follow-up. The case illustrated in Figure 1
had rapid recurrence, but the recurrent lesions were
widely separated, rather than having the appearance of a
diffuse malignant mesothelioma. The case shown
in Figure 3 had no evidence of recurrence at 3 years at
hemiscrotectomy. These findings suggest that even in the
cases in which the morphology mimics that of a malig-
nant mesothelioma, the functional behavior appears to be
low grade. It appears preferable to label such cases as
WDPM with invasive foci rather than malignant meso-
theliomas.
It is important to emphasize the differential diag-
nosis of WDPM with or without invasion. A particular
problem is ordinary diffuse malignant mesotheliomas that
are partially papillary; if a biopsy samples only the pap-
illary area, such a tumor can mimic WDPM. Often review
of the operative report will solve the problem, as diffuse
malignant mesotheliomas typically show either multiple
obviously malignant nodules or a confluent rind of tumor
on the serosal membranes, rather than the more delicate
and often translucent foci of WDPM. In addition, tumors
with WDPM-like papillary foci but obvious meso-
thelioma outside the papillae should be regarded as ma-
lignant mesotheliomas. Our data on the lack of p16
deletion in WDPM suggest that evaluation of p16 by
FISH may also be of use in defining cases that are ma-
lignant mesotheliomas, but we make that comment with
caution because of the small number of cases that were
analyzed by FISH and also because only a proportion of
diffuse malignant mesotheliomas show p16 deletion.9
Reactive mesothelium can also appear papillary,
but generally such papillae are small and lack any kind of
core or have fibrovascular cores rather than the myxoid
cores of WDPM. WDPMs, by contrast, always have a
distinctly papillary architecture with myxoid cores and
a single layer of cytologically bland mesothelial cells
covering the papillae and maintain this fundamental
structure, even if the tumor is several centimeters in
diameter.
In summary, this study suggests that WDPMs with
invasive foci within the papillae have a distinct tendency
toward multifocality and also toward recurrence and that
such recurrences may be frequent in a given patient. Ar-
guably the invasive foci represent early malignant meso-
thelioma in some cases, but because the development of
overt diffuse malignant mesothelioma in this setting seems
to be uncommon, we suggest calling these lesions WDPM
with invasive foci.
FIGURE 5. Invasive foci in a WDPM arising in the peritoneum at medium (A) and high (B) power (case 14). In a given field, these
patterns of growth mimic diffuse malignant mesotheliomas.
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